{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:18:42Z","timestamp":1792631922834,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a common and serious condition often associated with hypoalbuminemia, which can influence the pharmacokinetics and efficacy of diuretics like furosemide. In critically ill patients, sepsis is the major cause of AKI, accounting for nearly 50% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether AKI patients with hypoalbuminemia can respond to FST without albumin supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective quasi-experimental study. Patients were obtained from the intensive care unit of Cairo University Hospital with AKI stages 1 and 2 with hypoalbuminemia. A bolus of furosemide was administered at a dose calculated to be 1-1.5\u00a0mg\/kg in a single dose to patients without a prior diagnosis of kidney disease and clinical signs of hypovolemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 41 critically ill patients with AKI were enrolled, aged between 18 and 80 years, of whom 56.10% had diabetes mellitus, 53.70% were on at least one nephrotoxic medication, and 56.10% had sepsis as the cause of AKI. The median (IQR) albumin level was 1.9\u00a0g\/dL (1.4\u20132.7). Among 41 hypoalbuminemic AKI patients included, 80.50% responded to FST without prior albumin infusion. Non-responders had significantly lower baseline serum albumin levels, median (IQR) 1(1\u20132) vs. 2 (1\u20133) g\/dL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AKI patients with mild-to-moderate hypoalbuminemia may still respond to FST without albumin infusion, although response rates decline with the increasing severity of hypoalbuminemia. The FST remains a valuable predictive tool in hypoalbuminemic AKI patients but warrants further investigation to optimize its utility in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04532-2","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:01:20Z","timestamp":1764072080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors affecting response to furosemide stress test among critically ill hypoalbuminemic patients with AKI without prior albumin infusion"],"prefix":"10.1186","volume":"26","author":[{"given":"Amin Roshdy","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Yousry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda Abdelhamid","family":"Maamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"4532_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (kidney disease: improving global Outcomes). Crit Care. 2013;17(1):204. https:\/\/doi.org\/10.1186\/cc11454.","journal-title":"Crit Care"},{"issue":"9","key":"4532_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ki.2011.339","volume":"81","author":"K Singbartl","year":"2012","unstructured":"Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81(9):819\u201325.","journal-title":"Kidney Int"},{"issue":"8","key":"4532_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-5","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Kellum JA, Selby NM, Zarbock A, Shamim B, Ronco C. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411\u201323. https:\/\/doi.org\/10.1007\/s00134-015-3934-5.","journal-title":"Intensive Care Med"},{"key":"4532_CR4","doi-asserted-by":"publisher","unstructured":"Ferreira FL, Bota DP, Bross A, M\u00e9lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. Oct 2001;286(14):1754\u20138. https:\/\/doi.org\/10.1001\/jama.286.14.1754. PMID 11594901.","DOI":"10.1001\/jama.286.14.1754"},{"key":"4532_CR5","doi-asserted-by":"publisher","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287","DOI":"10.1001\/jama.2016.0287"},{"issue":"2","key":"4532_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1056\/NEJMra032401","volume":"351","author":"RW Schrier","year":"2004","unstructured":"Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351(2):159\u201369. https:\/\/doi.org\/10.1056\/NEJMra032401.","journal-title":"N Engl J Med"},{"issue":"1","key":"4532_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13054-016-1465-0","volume":"20","author":"JA Kellum","year":"2016","unstructured":"Kellum JA, Chawla LS. The Furosemide stress test: current use and future potential. Crit Care. 2016;20(1):274. https:\/\/doi.org\/10.1186\/s13054-016-1465-0.","journal-title":"Crit Care"},{"issue":"1","key":"4532_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000489946","volume":"140","author":"NE Tolkoff-Rubin","year":"2018","unstructured":"Tolkoff-Rubin NE, Rubin JA. Furosemide stress test as a method for assessing renal tubular function in early acute kidney injury. Nephron. 2018;140(1):18\u201323. https:\/\/doi.org\/10.1159\/000489946.","journal-title":"Nephron"},{"issue":"3","key":"4532_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/CCM.0000000000002139","volume":"45","author":"JA Kellum","year":"2017","unstructured":"Kellum JA, Chawla LS. The effects of Furosemide in acute kidney injury: why the response varies. Crit Care Med. 2017;45(3):543\u201350. https:\/\/doi.org\/10.1097\/CCM.0000000000002139.","journal-title":"Crit Care Med"},{"key":"4532_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcrc.2019.11.004","volume":"55","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Wang Y. Impact of hypoalbuminemia on the response to Furosemide in critically ill patients with acute kidney injury: A clinical evaluation of the Furosemide stress test. J Crit Care. 2020;55:14\u201322. https:\/\/doi.org\/10.1016\/j.jcrc.2019.11.004.","journal-title":"J Crit Care"},{"issue":"8","key":"4532_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/CCM.0000000000005162","volume":"49","author":"BA McMahon","year":"2021","unstructured":"McMahon BA, Chawla LS, Patel NR. Diuretic response in acute kidney injury: A multicenter analysis of Furosemide efficacy and its implications in critically ill patients. Crit Care Med. 2021;49(8):1340\u20137. https:\/\/doi.org\/10.1097\/CCM.0000000000005162.","journal-title":"Crit Care Med"},{"issue":"6","key":"4532_CR12","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/CCM.0000000000000960","volume":"43","author":"RM Smith","year":"2015","unstructured":"Smith RM, Adams CB. The impact of hypoalbuminemia on Furosemide pharmacokinetics in critically ill patients. Crit Care Med. 2015;43(6):1212\u20138. https:\/\/doi.org\/10.1097\/CCM.0000000000000960.","journal-title":"Crit Care Med"},{"issue":"10","key":"4532_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/ndt\/gfx049","volume":"32","author":"LA Johnson","year":"2017","unstructured":"Johnson LA, Patel VM, Brown JT. Influence of hypoalbuminemia on the pharmacodynamics of Furosemide in acute kidney injury. Nephrol Dialysis Transplantation. 2017;32(10):1744\u201350. https:\/\/doi.org\/10.1093\/ndt\/gfx049.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4532_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jcrc.2018.11.022","volume":"50","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Hasan S, Rahman A. Effective diuretic response without albumin supplementation in mild-to-moderate hypoalbuminemia in critically ill patients. J Crit Care. 2019;50:132\u20139. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.022.","journal-title":"J Crit Care"},{"issue":"5","key":"4532_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/CCM.0000000000004924","volume":"49","author":"JT Brown","year":"2021","unstructured":"Brown JT, Patel S, Richards JD. The effects of severe hypoalbuminemia on diuretic response in critically ill patients. Crit Care Med. 2021;49(5):754\u201362. https:\/\/doi.org\/10.1097\/CCM.0000000000004924.","journal-title":"Crit Care Med"},{"issue":"85","key":"4532_CR16","doi-asserted-by":"publisher","first-page":"154929","DOI":"10.1016\/j.jcrc.2024.154929","volume":"Feb","author":"L Xu","year":"2025","unstructured":"Xu L, Chen L, Jiang X, Hu W, Gong S, Fang J. The Furosemide stress test predicts successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. J Crit Care. 2025;Feb(85):154929. https:\/\/doi.org\/10.1016\/j.jcrc.2024.154929.","journal-title":"J Crit Care"},{"key":"4532_CR17","doi-asserted-by":"publisher","unstructured":"Tripodi A, Daidone V, Zappulo F, Pisani A, Capone V, Scala M, Bolino G, Polito MG. Furosemide stress test compared with urine neutrophil gelatinase-associated lipocalin and fractional excretion of sodium for predicting acute kidney injury. Kidney Int Rep. 2018 Oct;33:242\u20137. https:\/\/doi.org\/10.1016\/j.ekir.2018.08.020. PMID: 30225802.","DOI":"10.1016\/j.ekir.2018.08.020"},{"key":"4532_CR18","doi-asserted-by":"publisher","unstructured":"Ehrenpreis ED, Elhanafi S, Nagar S, Aferzon M, Rao S. Furosemide stress test in critically ill patients with acute kidney injury. J Crit Care. 2016 Jun; 33:242-7. https:\/\/doi.org\/10.1016\/j.jcrc.03.037. PMID: 27183025.","DOI":"10.1016\/j.jcrc.03.037"},{"issue":"5","key":"4532_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/CCM.0000000000004925","volume":"49","author":"JT Brown","year":"2021","unstructured":"Brown JT, Patel S, Richards JD. Diuretic response in critically ill patients: mechanisms and clinical implications. Crit Care Med. 2021;49(5):763\u201370. https:\/\/doi.org\/10.1097\/CCM.0000000000004925.","journal-title":"Crit Care Med"},{"key":"4532_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcrc.2022.01.005","volume":"63","author":"RM Smith","year":"2022","unstructured":"Smith RM, Zhang H, Lee DA. Future directions in critical care nephrology: exploring diuretic response, albumin supplementation, and personalized treatment strategies. J Crit Care. 2022;63:51\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2022.01.005.","journal-title":"J Crit Care"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04532-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:01:20Z","timestamp":1764072080000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04532-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4532"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04532-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6288472\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki, as reflected in its prior approval by the institution\u2019s human research committee. The Kasr Alainy School of Medicine ethical committee approved the study protocol, Cairo University, Egypt. The ethical approval number is N-381-2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}